Is Aarti Drugs Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Aarti Drugs Ltd (AARTIDRUGS.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Aarti Drugs Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Aarti Drugs Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Aarti Drugs Ltd?

Muslim investors may consider investing in Aarti Drugs Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Aarti Drugs Ltd classified as HALAL?

Musaffa determines the Shariah status of Aarti Drugs Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Aarti Drugs Ltd updated?

The Shariah compliance status of Aarti Drugs Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Aarti Drugs Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Aarti Drugs Ltd?

You can check the latest Shariah compliance status of Aarti Drugs Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

AARTIDRUGS.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 24, 2026

Report Source: 2026 3rd Quarter Report

Aarti Drugs Ltd. Stock Analysis AARTIDRUGS.NS

India Health Care Small Cap Report: Q3, 2026

Aarti Drugs Ltd. engages in the development, manufacture and market of pharmaceutical products. The firm operates in the pharmaceuticals segment. Its geographical segments include Out of India and India. The firm's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals include benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The firm's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.

Key Statistics of Aarti Drugs Ltd (AARTIDRUGS.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹360.00₹374.80

Today's Open

₹366.00

Volume

207.08K

P/E Ratio (TTM)

19.70

52 Week Range

₹318.95₹564.05

Market Cap

36.04B

Avg. Volume

163.27K

Dividend Yield

Financial Metrics & Statements of Aarti Drugs Ltd (AARTIDRUGS.NS)

FAQ's for Aarti Drugs Ltd (AARTIDRUGS.NS)

According to Musaffa’s Shariah screening methodology, Aarti Drugs Ltd (AARTIDRUGS.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.